Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series

Author(s): Rakhmad Hidayat*, Dinda Diafiri, Ramdinal Aviesena Zairinal, Ghafur Rasyid Arifin, Faiza Azzahroh, Nita Widjaya, Devi Nurfadila Fani, Taufik Mesiano, Mohammad Kurniawan, Al Rasyid, Astuti Giantini and Salim Haris

Volume 18, Issue 3, 2021

Published on: 27 September, 2021

Page: [360 - 363] Pages: 4

DOI: 10.2174/1567202618666210927095613

open access plus

Abstract

Background: Coronavirus disease-19 (COVID-19) is an infectious disease with high morbidity and mortality rates. Indonesia had reported a 2.8% of mortality rate up to June 2021.

Case Presentation: A strategy to control the virus spreading is by vaccination. The Indonesian Food and Drug Monitoring Agency had approved the use of CoronaVac, an inactivated virus vaccine developed by Sinovac. Most Adverse Events Following Immunization (AEFI) for Corona- Vac are mild, and the most common symptoms are injection-site pain, headache, and fatigue. Neurovascular adverse events, including thrombosis or ischaemic stroke after receiving CoronaVac have not previously been reported.

Conclusion: Correspondingly, we reported three patients with an Acute Ischaemic Stroke (AIS) after the administration of CoronaVac in our hospital.

Keywords: CoronaVac, COVID-19, stroke, vaccine, AEFI, COVID 19.

« Previous Next »
[1]
Yesudhas D, Srivastava A, Gromiha MM. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection 2021; 49(2): 199-213.
[http://dx.doi.org/10.1007/s15010-020-01516-2] [PMID: 32886331]
[2]
Khan M, Adil SF, Alkhathlan HZ, et al. COVID-19: A global challenge with old history, epidemiology and progress so far. Molecules 2020; 26(1): E39.
[http://dx.doi.org/10.3390/molecules26010039] [PMID: 33374759]
[3]
Tosepu R, Effendy DS. The first confirmed cases of covid-19 in Indonesian citizens. PHI 2020; 6(92): 70-1.
[http://dx.doi.org/10.36685/phi.v6i2.337]
[4]
Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Health West Pac 2021.
[5]
WHO Evidence Assessment - SinovacCoronaVac COVID-19 vaccine 2021. Available from: https://cdn.who.int/media/docs/default-source/immunization/sage/2021/april/5_sage 29apr2021_critical-evidence_sinovac.pdf
[6]
Koesnoe S. Teknis pelaksanaan vaksin COVID-19 dan antisipasi KIPI Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia 2021. Available from: https://www.papdi.or.id/pdfs/1001/Dr%20Sukamto%20-%20Ws%20Vaksin%20Covid% 20KIPI.pdf
[7]
Act sheet for health care providers coronavac with elderly englishcoronavac suspensi injeksi 3mcg,0,5mL_SARS-COV-2 virus (inactivated) EUA2057300143A1, 2021.
[8]
Nugraha R. 27 deaths post sinovac vaccination related to comorbidity: Covid-19 task force Tempo 2021. Available from: https://en.tempo.co/read/1466188/27-deaths-post-sinovac-vaccination-related-to-comorbidity-covid-19-task-force
[9]
Kleindorfer D, Towfighi A, Chaturvedi S, Cockroft K, Gutierrez J, Lombardi-Hill D. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the american heart association/american stroke associationAHA. 2021.
[10]
Li C, Engström G, Hedblad B, Berglund G, Janzon L. Blood pressure control and risk of stroke: A population-based prospective cohort study. Stroke 2005; 36(4): 725-30.
[http://dx.doi.org/10.1161/01.STR.0000158925.12740.87] [PMID: 15746450]
[11]
Khanevski AN, Bjerkreim AT, Novotny V, et al. Recurrent ischemic stroke: Incidence, predictors, and impact on mortality. Acta Neurol Scand 2019; 140(1): 3-8.
[http://dx.doi.org/10.1111/ane.13093] [PMID: 30929256]
[12]
Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24(1): 35-41.
[http://dx.doi.org/10.1161/01.STR.24.1.35] [PMID: 7678184]
[13]
Mangla R, Kolar B, Almast J, Ekholm SE. Border zone infarcts: pathophysiologic and imaging characteristics. Radiographics 2011; 31(5): 1201-14.
[http://dx.doi.org/10.1148/rg.315105014] [PMID: 21918038]
[14]
Leonards CO, Ipsen N, Malzahn U, Fiebach JB, Endres M, Ebinger M. White matter lesion severity in mild acute ischemic stroke patients and functional outcome after 1 year. Stroke 2012; 43(11): 3046-51.
[http://dx.doi.org/10.1161/STROKEAHA.111.646554] [PMID: 22935398]
[15]
Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013; 369(1): 11-9.
[http://dx.doi.org/10.1056/NEJMoa1215340] [PMID: 23803136]
[16]
PAPDI. Rekomendasi PAPDI tentang pemberian vaksinasi COVID-19 pada pasien dengan penyakit penyerta/komorbid. Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia 2021.
[17]
Al-Mayhani T, Saber S, Stubbs MJ, et al. Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. J Neurol Neurosurg Psychiatry 2021 2021; 326984.
[http://dx.doi.org/10.1136/jnnp-2021-326984] [PMID: 34035134]
[18]
Su JR, Lale A, Woo EJ, Guh AY. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination. JAMA 202 2020: 396.

Rights & Permissions Print Cite
Article Metrics
41
1
© 2024 Bentham Science Publishers | Privacy Policy